S. Johnston

2.6k total citations
50 papers, 923 citations indexed

About

S. Johnston is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, S. Johnston has authored 50 papers receiving a total of 923 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 24 papers in Pulmonary and Respiratory Medicine and 16 papers in Genetics. Recurrent topics in S. Johnston's work include HER2/EGFR in Cancer Research (19 papers), Advanced Breast Cancer Therapies (17 papers) and Estrogen and related hormone effects (13 papers). S. Johnston is often cited by papers focused on HER2/EGFR in Cancer Research (19 papers), Advanced Breast Cancer Therapies (17 papers) and Estrogen and related hormone effects (13 papers). S. Johnston collaborates with scholars based in United Kingdom, United States and France. S. Johnston's co-authors include Mitch Dowsett, Ian E. Smith, Janine Salter, Simone Detre, Lloyd R. Kèlland, Michael Jarman, Gloria Saccani Jotti, KA MacLennan, IE Smith and S. Jacobs and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Cancer.

In The Last Decade

S. Johnston

48 papers receiving 885 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Johnston United Kingdom 18 508 371 265 262 212 50 923
Barbara Dunne United Kingdom 12 482 0.9× 241 0.6× 536 2.0× 230 0.9× 172 0.8× 21 973
Lavina Bharwani Singapore 9 491 1.0× 289 0.8× 356 1.3× 149 0.6× 179 0.8× 13 861
B. Lisboa Germany 12 474 0.9× 207 0.6× 203 0.8× 376 1.4× 100 0.5× 23 788
S. Ashley United Kingdom 9 772 1.5× 331 0.9× 234 0.9× 432 1.6× 133 0.6× 12 1.1k
J.G.M. Klijn Netherlands 8 539 1.1× 237 0.6× 249 0.9× 251 1.0× 170 0.8× 19 840
Ulla Johansson Sweden 16 598 1.2× 261 0.7× 272 1.0× 493 1.9× 200 0.9× 21 1.1k
A McKinna United Kingdom 11 407 0.8× 210 0.6× 255 1.0× 232 0.9× 125 0.6× 14 756
Aiko Sueta Japan 18 340 0.7× 157 0.4× 455 1.7× 487 1.9× 185 0.9× 45 947
Yoshiaki Rai Japan 21 827 1.6× 155 0.4× 193 0.7× 421 1.6× 310 1.5× 55 1.2k
Eleanor Gutteridge United Kingdom 8 553 1.1× 147 0.4× 214 0.8× 200 0.8× 268 1.3× 27 800

Countries citing papers authored by S. Johnston

Since Specialization
Citations

This map shows the geographic impact of S. Johnston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Johnston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Johnston more than expected).

Fields of papers citing papers by S. Johnston

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Johnston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Johnston. The network helps show where S. Johnston may publish in the future.

Co-authorship network of co-authors of S. Johnston

This figure shows the co-authorship network connecting the top 25 collaborators of S. Johnston. A scholar is included among the top collaborators of S. Johnston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Johnston. S. Johnston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
García-Murillas, Isaac, Charles W. Abbott, Rosalind Cutts, et al.. (2025). Whole genome sequencing-powered ctDNA sequencing for breast cancer detection. Annals of Oncology. 36(6). 673–681. 10 indexed citations
2.
Johnston, S., Nadia Harbeck, Roberto Hegg, et al.. (2020). 2MO Abemaciclib in high risk early breast cancer. Annals of Oncology. 31. S1242–S1243. 2 indexed citations
3.
Osin, Peter, Ashutosh Nerurkar, Ian C. P. Smith, et al.. (2019). Clinical Outcomes in Triple-negative Lobular Breast Cancer: a Single-institution Experience. Clinical Oncology. 31(7). e110–e110. 1 indexed citations
4.
Michiels, Stefan, Lina Pugliano, Sophie Marguet, et al.. (2016). Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer. Annals of Oncology. 27(6). 1029–1034. 31 indexed citations
5.
O’Shaughnessy, Joyce, Mario Campone, Étienne Brain, et al.. (2015). Abiraterone acetate, exemestane or the combination in postmenopausal patients with estrogen receptor-positive metastatic breast cancer. Annals of Oncology. 27(1). 106–113. 54 indexed citations
6.
Hoenich, Nicholas A., S. Johnston, C. Woffindin, & D. N. S. Kerr. (2015). Haemodialysis Leucopenia: The Role of Membrane Type and Re-use. Contributions to nephrology. 37. 120–128.
7.
Roder, Joanna, Heinrich Röder, Julia Grigorieva, et al.. (2011). S1-4: Retrospective Analysis of Study EGF30008 by Mass-Spectrometry Based Serum Assay (VeriStrat®).. Cancer Research. 71(24_Supplement). S1–4. 2 indexed citations
8.
Constantinidou, Anastasia, Antonio Félix Conde-Martín, Bhupinder Sharma, & S. Johnston. (2010). Positron emission tomography/computed tomography in the management of recurrent/metastatic breast cancer: a large retrospective study from the Royal Marsden Hospital. Annals of Oncology. 22(2). 307–314. 36 indexed citations
9.
Dowsett, M, S. Johnston, Janine Salter, et al.. (2005). Growth factor signalling and response to endocrine therapy: the Royal Marsden Experience. Endocrine Related Cancer. 12(Supplement_1). S113–S117. 33 indexed citations
10.
11.
Johnston, S. & Lloyd R. Kèlland. (2001). Farnesyl transferase inhibitors--a novel therapy for breast cancer.. Endocrine Related Cancer. 8(3). 227–235. 30 indexed citations
12.
Boer, Richard H. De, W H Allum, S. Ebbs, et al.. (2000). Multimodality therapy in inflammatory breast cancer: Is there a place for surgery?. Annals of Oncology. 11(9). 1147–1154. 34 indexed citations
13.
Dowsett, Mitch, Caroline Archer, L. Assersohn, et al.. (1999). Clinical studies of apoptosis and proliferation in breast cancer.. Endocrine Related Cancer. 6(1). 25–28. 46 indexed citations
14.
Palmer, Kay, J. Moore, Robert C. Rees, et al.. (1999). Gene Therapy with Autologous, Interleukin 2-Secreting Tumor Cells in Patients with Malignant Melanoma. Human Gene Therapy. 10(8). 1261–1268. 66 indexed citations
15.
Howell, Anthony, Elizabeth Anderson, R.W. Blamey, et al.. (1998). The Primary Use of Endocrine Therapies. Recent results in cancer research. 152. 227–244. 21 indexed citations
16.
Johnston, S., et al.. (1994). Modulation of Bcl-2 and Ki-67 expression in oestrogen receptor-positive human breast cancer by tamoxifen. European Journal of Cancer. 30(11). 1663–1669. 61 indexed citations
17.
Johnston, S., Mitch Dowsett, IE Smith, et al.. (1993). Acquired tamoxifen resistance in human breast cancer and reduced intra-tumoral drug concentration. The Lancet. 342(8886-8887). 1521–1522. 65 indexed citations
18.
Johnston, S., Ben P. Haynes, Nigel Sacks, et al.. (1993). Effect of oestrogen receptor status and time on the intra-tumoural accumulation of tamoxifen and N-desmethyltamoxifen following short-term therapy in human primary breast cancer. Breast Cancer Research and Treatment. 28(3). 241–250. 38 indexed citations
19.
Johnston, S., et al.. (1992). Towards a molecular basis for tamoxifen resistance in breast cancer. Annals of Oncology. 3(7). 503–511. 46 indexed citations
20.
Johnston, S. & Peter L. Wright. (1990). Control of metastatic Zollinger‐Ellison syndrome with high‐dose H2‐receptor antagonists. International Journal of Clinical Practice. 44(12). 792–793. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barbara Dunne Breakdown of academic impact, for papers by Lavina Bharwani Breakdown of academic impact, for papers by B. Lisboa Breakdown of academic impact, for papers by S. Ashley Breakdown of academic impact, for papers by J.G.M. Klijn Breakdown of academic impact, for papers by Ulla Johansson Breakdown of academic impact, for papers by A McKinna Breakdown of academic impact, for papers by Aiko Sueta Breakdown of academic impact, for papers by Yoshiaki Rai Breakdown of academic impact, for papers by Eleanor Gutteridge
Rankless by CCL
2026